JP2014167010A5 - - Google Patents

Download PDF

Info

Publication number
JP2014167010A5
JP2014167010A5 JP2014090998A JP2014090998A JP2014167010A5 JP 2014167010 A5 JP2014167010 A5 JP 2014167010A5 JP 2014090998 A JP2014090998 A JP 2014090998A JP 2014090998 A JP2014090998 A JP 2014090998A JP 2014167010 A5 JP2014167010 A5 JP 2014167010A5
Authority
JP
Japan
Prior art keywords
use according
dermatophyte
infection
trichophyton
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014090998A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014167010A (ja
JP6199797B2 (ja
Filing date
Publication date
Priority claimed from GBGB0526120.1A external-priority patent/GB0526120D0/en
Application filed filed Critical
Publication of JP2014167010A publication Critical patent/JP2014167010A/ja
Publication of JP2014167010A5 publication Critical patent/JP2014167010A5/ja
Application granted granted Critical
Publication of JP6199797B2 publication Critical patent/JP6199797B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014090998A 2005-12-22 2014-04-25 環状抗微生物ペプチド Expired - Fee Related JP6199797B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0526120.1 2005-12-22
GBGB0526120.1A GB0526120D0 (en) 2005-12-22 2005-12-22 Therapeutic peptides
US77650506P 2006-02-24 2006-02-24
US60/776,505 2006-02-24

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008546630A Division JP5559477B2 (ja) 2005-12-22 2006-12-21 環状抗微生物ペプチド

Publications (3)

Publication Number Publication Date
JP2014167010A JP2014167010A (ja) 2014-09-11
JP2014167010A5 true JP2014167010A5 (enExample) 2014-12-18
JP6199797B2 JP6199797B2 (ja) 2017-09-20

Family

ID=37836928

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008546630A Expired - Fee Related JP5559477B2 (ja) 2005-12-22 2006-12-21 環状抗微生物ペプチド
JP2012252220A Expired - Fee Related JP6050096B2 (ja) 2005-12-22 2012-11-16 環状抗微生物ペプチド
JP2014090998A Expired - Fee Related JP6199797B2 (ja) 2005-12-22 2014-04-25 環状抗微生物ペプチド

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008546630A Expired - Fee Related JP5559477B2 (ja) 2005-12-22 2006-12-21 環状抗微生物ペプチド
JP2012252220A Expired - Fee Related JP6050096B2 (ja) 2005-12-22 2012-11-16 環状抗微生物ペプチド

Country Status (14)

Country Link
US (2) US8324154B2 (enExample)
EP (4) EP2357190A3 (enExample)
JP (3) JP5559477B2 (enExample)
KR (1) KR101413746B1 (enExample)
AU (1) AU2006327973B2 (enExample)
CA (1) CA2655448C (enExample)
CY (1) CY1113770T1 (enExample)
IL (2) IL192373A (enExample)
MX (1) MX2008008291A (enExample)
NO (1) NO346186B1 (enExample)
PL (1) PL1976863T3 (enExample)
RU (1) RU2463308C2 (enExample)
WO (1) WO2007072037A1 (enExample)
ZA (1) ZA200806329B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2357190A3 (en) * 2005-12-22 2011-08-24 Novabiotics Limited Cyclic antimicrobial peptides
GB0702020D0 (en) * 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
US20110039762A1 (en) * 2009-01-06 2011-02-17 C3 Jian, Inc. Targeted antimicrobial moieties
EP2694085A4 (en) * 2011-04-01 2015-02-11 Univ Northeastern PROCESS FOR EXPLORING BACTERIAL CELL POPULATIONS
CA2859720A1 (en) * 2011-12-21 2013-06-27 Regents Of The University Of Minnesota Cationic peptides and use of such peptides for inhibiting exotoxin production
KR101502797B1 (ko) * 2012-08-22 2015-03-17 연세대학교 산학협력단 신규한 양친매성　고리형 펩티드, 이의 제조방법 및 이를 포함하는 안정한 자기조립 나노전달체
US9082888B2 (en) 2012-10-17 2015-07-14 New York University Inverted orthogonal spin transfer layer stack
RS59119B1 (sr) 2014-05-21 2019-09-30 Entrada Therapeutics Inc Peptidi koji prodiru u ćelije i postupci za njihovo pravljenje i upotrebu
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
WO2016033368A1 (en) 2014-08-27 2016-03-03 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
WO2016154328A2 (en) * 2015-03-23 2016-09-29 Riptide Bioscience, Inc. Antimicrobial peptides and methods of use thereof
KR101692992B1 (ko) 2015-05-20 2017-01-17 연세대학교 산학협력단 고리형 펩타이드의 사전 활성화 합성방법 및 이에 따라 합성된 고리형 펩타이드
CA3078504A1 (en) 2017-10-04 2019-04-11 Ohio State Innovation Foundation Bicyclic peptidyl inhibitors
WO2019148194A2 (en) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-nfat interaction
US11793884B2 (en) 2018-01-29 2023-10-24 Ohio State Innovation Foundation Cyclic peptidyl inhibitors of CAL-PDZ binding domain
TW201945014A (zh) 2018-02-22 2019-12-01 美商安卓達治療股份有限公司 用於治療粒線體性神經胃腸腦病變之組合物及方法
US11987647B2 (en) 2018-05-09 2024-05-21 Ohio State Innovation Foundation Cyclic cell-penetrating peptides with one or more hydrophobic residues
CA3134420A1 (en) 2019-04-12 2020-10-15 Riptide Bioscience, Inc. Methods for modulating macrophage activity
GB202010268D0 (en) * 2020-07-03 2020-08-19 Novabiotics Ltd Nail formulations and treatment regimes
CN115716865B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-苏-酪-缬-亮肽及制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
DE2626348C3 (de) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4962091A (en) 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
CA2145093C (en) 1992-09-25 2007-04-10 Lawrence Leroy Kunz Therapeutic inhibitor of vascular smooth muscle cells
US5858974A (en) * 1995-07-20 1999-01-12 Xoma Corporation Anti-fungal peptides
DE19534177A1 (de) * 1995-09-15 1997-03-20 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity
US6096707A (en) * 1997-07-11 2000-08-01 Biotie Therapies Ltd. Integrin binding peptide and use thereof
US6951652B2 (en) * 1998-07-29 2005-10-04 Biosynth S.R.L. Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases
CA2446322A1 (en) * 2001-05-04 2002-11-14 M. Reza Ghadiri Anti-microbial peptides and compositions
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
AU2003228896A1 (en) * 2002-05-06 2003-11-17 The Scripps Research Institute Anti-microbial peptides and compositions
WO2004050685A2 (en) * 2002-11-29 2004-06-17 Adaptive Therapeutics, Inc. Antifungal therapeutic agents
US6783677B1 (en) * 2003-02-06 2004-08-31 Mayyar Systems, Inc. Anaerobic film biogas digester system
EP1633380A4 (en) * 2003-06-19 2010-08-11 Yeda Res & Dev ANTIMICROBIAL AND ANTICANCER LIPOPEPTIDES
EP1778720B1 (en) 2004-08-18 2010-09-01 Novabiotics Limited Antimicrobial peptides comprising an arginine- and/or lysine-containing motif
EP2357190A3 (en) * 2005-12-22 2011-08-24 Novabiotics Limited Cyclic antimicrobial peptides

Similar Documents

Publication Publication Date Title
JP2014167010A5 (enExample)
JP2014515013A5 (enExample)
PH12020551089A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
JP2013032389A5 (enExample)
WO2013123215A3 (en) Antiviral drugs for treatment of arenavirus infection
JP2017537066A5 (enExample)
CN110248926A (zh) Lsd1抑制剂及其制备方法和应用
JP2013518107A5 (enExample)
MX374497B (es) Inhibidor del antígeno de superficie del virus de la hepatitis b.
NZ748966A (en) Functionalized benzamide derivatives as antiviral agents against hbv infection
PH12018500904A1 (en) Peptide macrocycles against acinetobacter baumannii
JP2013520405A5 (enExample)
NZ732391A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
JP2013509429A5 (enExample)
EA026667B9 (ru) Фармацевтическая композиция для лечения вируса гепатита с
PH12014501937B1 (en) Pharmaceutical composition containing an antivirally active dihydroquinazoline derivative
JP2008533007A5 (enExample)
EA032938B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
MX2016008665A (es) Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo.
AR085856A1 (es) Formas cristalinas del acido (2s)-2-ter-butoxi-2-(4-(2,3-dihidropirano[4,3,2-de]quinolin-7-il)-2-metilquinolin-3-il)acetico
EA201691538A1 (ru) Способ получения солей вортиоксетина
JP2015516419A5 (enExample)
JP2017518982A5 (enExample)
RU2017145271A (ru) Терапевтическое средство для фиброза
JP2016532632A5 (enExample)